AktS473 phosphorylation and primary CLL cell viability was also reduced by the combination of FoxO1 inhibitor with acalabrutinib or pirtobrutinib (Supplemental Figure 9, B and C). The gene discussed is FOXO1; the disease is B-cell chronic lymphocytic leukemia.